Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Simple or combined DNA methyltransferase antisense therapy effective against gastric, renal cancer

April 21, 2004

Extensive data presented on AZD-2171, a potent VEGF receptor tyrosine kinase inhibitor

April 20, 2004

Discovery of SSX-2 offers new target for development of melanoma vaccine

April 20, 2004

Eurand and U. of Urbino enter anticancer research agreement

April 20, 2004

Preclinical studies evaluate EOquin in combination with radiation therapy

April 20, 2004

New HDAC inhibitors isolated from Pseudomonas cultures

April 20, 2004

Promising second generation vascular targeting agent

April 20, 2004

Gloucester Pharmaceuticals acquires license to FK-228

April 19, 2004

New phase I trial for VEGF Trap

April 19, 2004

CB-300945, a novel selective alpha-FR targeted thymidylate synthase inhibitor

April 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...